Oorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic Diseases

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. ABBV
7. DFTX
8. RGNX
9. GOOGL
10. LCO

Go back to Oorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic Diseases
(NASDAQ: DNTH) Delayed: 86.86 +4.37 (5.30%)
Previous Close $82.49    52 Week High $ 
Open $85.16    52 Week Low $ 
Day High $87.38    P/E N/A 
Day Low $83.91    EPS $ 
Volume 151,771